Literature DB >> 7049799

Interrelationships of microangiopathy, plasma glucose and other risk factors in 3583 diabetic patients: a multinational study.

K M West, M M Ahuja, P H Bennett, B Grab, V Grabauskas, O Mateo-de-Acosta, J H Fuller, R J Jarrett, H Keen, K Kosaka, A S Krolewski, E Miki, V Schliack, A Teuscher.   

Abstract

In a multinational study, fasting plasma glucose values in 3583 diabetic patients, aged 34-56 years, were related to the characteristics of these subjects and to the presence and severity of microangiopathy as ascertained by standardised methods. The patients were from nine different populations and ranged in number from 193 to 686 per population (London, Warsaw, Berlin (FRG), New Delhi, Tokyo, Havana, Oklahoma Indians, Arizona Pima Indians, and a national sample in Switzerland). In the total group, mean fasting plasma glucose was 8.1 mmol/l for those on diet alone, 9.7 mmol/l for those on oral agents, and 12.7 mmol/l for insulin-treated patients, of whom 25% had values exceeding 16.5 mmol/l. Since many variables were measured in each patient, it was possible to take into account many confounding factors in evaluating the relationship of plasma glucose levels to retinopathy and nephropathy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7049799     DOI: 10.1007/bf00282582

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  6 in total

Review 1.  Methods for determining the amount of glucose in blood.

Authors:  G R Cooper
Journal:  CRC Crit Rev Clin Lab Sci       Date:  1973-08

2.  Computing and expressing degree of fatness.

Authors:  K M West
Journal:  JAMA       Date:  1980-04-11       Impact factor: 56.272

3.  A detailed study of risk factors for retinopathy and nephropathy in diabetes.

Authors:  K M West; L J Erdreich; J A Stober
Journal:  Diabetes       Date:  1980-07       Impact factor: 9.461

4.  The WHO multinational study of vascular disease in diabetes: 3. Microvascular disease.

Authors:  R J Jarrett; H Keen
Journal:  Diabetes Care       Date:  1979 Mar-Apr       Impact factor: 19.112

5.  The WHO multinational study of vascular disease in diabetes: 1. General description.

Authors:  R J Jarrett; H Keen; V Grabauskas
Journal:  Diabetes Care       Date:  1979 Mar-Apr       Impact factor: 19.112

6.  The WHO multinational study of vascular disease in diabetes: 2. Macrovascular disease prevalence.

Authors:  H Keen; R J Jarrett
Journal:  Diabetes Care       Date:  1979 Mar-Apr       Impact factor: 19.112

  6 in total
  5 in total

1.  Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. The World Health Organisation Multinational Study of Vascular Disease in Diabetics. Diabetes Drafting Group.

Authors: 
Journal:  Diabetologia       Date:  1985-09       Impact factor: 10.122

2.  Residual B-cell function in insulin-dependent (type I) diabetics with and without retinopathy.

Authors:  P Sberna; U Valentini; A Cimino; M C Sabatti; A Rotondi; M Crisetig; S Spandrio
Journal:  Acta Diabetol Lat       Date:  1986 Oct-Dec

3.  Genetic and metabolic risk factors for the development of late complications in type I (insulin-dependent) diabetes.

Authors:  A E Pontiroli; A Calderara; L Bonisolli; P Maffi; A De Pasqua; A Margonato; G Radaelli; G Gallus; G Pozza
Journal:  Acta Diabetol Lat       Date:  1986 Oct-Dec

4.  [Vascular diseases in 534 Swiss diabetics within the scope of a multinational study].

Authors:  A Teuscher; J B Herman; P P Studer
Journal:  Klin Wochenschr       Date:  1983-02-01

5.  Ethnic differences in the prevalence of diabetic retinopathy in persons with diabetes when first presenting at a diabetes clinic in South Africa.

Authors:  Rebecca L Thomas; Larry Distiller; Stephen D Luzio; Sharmistha Roy Chowdhury; Vanessa J Melville; Brian Kramer; David R Owens
Journal:  Diabetes Care       Date:  2012-10-01       Impact factor: 19.112

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.